Clinical Trial Update: Incretin Effect on the Immunological Phenotype [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of incretin on the immunological phenotype in people with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Medical University of Graz | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED